
Bulletin of the Chemical Society of Japan p. 1827 - 1835 (1999)
Update date:2022-08-05
Topics:
Iwai, Michio
Yamada, Hisashi
Ishii, Yoshinori
Tamura, Kouichi
Niwa, Mineo
Kobayashi, Masakazu
The primary structure of human IGF-I, except for the disulfide bond system, has been reported by Rinderknecht and Humbel. IGF-I afforded the corresponding characteristic peptide fragments on V8 protease digestion, which contained Cys6, Cys47, Cys48, and Cys52. Two possible fragments, Type I with Cys6-Cys47 and Cys48-Cys52 and Type II with Cys6-Cys48 and Cys47-Cys52 of h-IGF-I(4-9,47-53), were chemically synthesized. The disulfide bond system of IGF-I was unequivocally determined to be the Type-II form along with Cys18-Cys61. Interestingly, the Type-I system was included in the disulfide bond isomer produced as the main by-product in the refolding step on IGF-I synthesis by the recombinant DNA method.
View MoreNanjing lanbai chemical Co.,Ltd.
Contact:+86-25-85499326
Address:Room 908, 9F Taiyue Building,No.285 Heyan Road
Laizhou City Laiyu Chemical CO.,Ltd
Contact:+86-535-2719337/2719339
Address:Chenggang road zhuyou laizhou City Shangdong China
Shantou Baokang Pharmaceutical Co., Ltd.
Contact:+86-754-88873487
Address:5/F B Block Huangshan Bldg Huangshan Rd Shantou
Suzhou Time-chem Technologies Co., Ltd.
Contact:0512-63983931/68086856
Address:No. 1326 of Binhe Road, New District, Suzhou, Jiangsu, P. R. China
Tianjin Realet Chemical Technology Co.,Ltd.
website:http://www.realetchem.com
Contact:+86-022-58788819
Address:shuanggang industrial park
Doi:10.1016/S0022-328X(99)00261-2
(1999)Doi:10.1021/acs.orglett.7b02109
(2017)Doi:10.1039/c5gc01333j
(2015)Doi:10.1016/S0960-894X(02)00537-1
(2002)Doi:10.1016/j.ejmech.2015.07.023
(2015)Doi:10.1021/jo026582f
(2003)